Browse Category

NASDAQ:PVLA News 16 December 2025

Biotech Stocks Today: FDA Fast Track Wins, PDUFA Delays and Deal Flow Move GLUE, ALDX, ADAG, PVLA as XBI and IBB Slide

Biotech Stocks Today: FDA Fast Track Wins, PDUFA Delays and Deal Flow Move GLUE, ALDX, ADAG, PVLA as XBI and IBB Slide

Updated: Tuesday, December 16, 2025 | Early afternoon ET (U.S. stock market) Biotechnology stocks are delivering a classic split-screen session in the U.S. market today: biotech ETFs are slipping, but a handful of single-name biotech movers are swinging sharply on FDA updates, clinical data, and year-end dealmaking. By early afternoon in New York (based on the latest available quotes at the time of…

Stock Market Today

  • OCBC Shares Edge Lower as Investors Assess CEO Tan's Strategic Flexibility
    February 5, 2026, 3:05 AM EST. Shares of Oversea-Chinese Banking Corporation Limited (OCBC) slipped 0.14% to S$21.41 on Thursday, trading close to recent peaks. The bank revealed the use of 76,300 treasury shares, previously repurchased stock, to fund employee share schemes, reflecting ongoing capital management. Investors are focused on the upcoming full-year 2025 results due Feb. 25 for clues on dividends, share buybacks, and CEO Tan Teck Long's approach to managing capital and growth. Market sentiment turned cautious amid global tech sell-offs and concerns over AI investment costs. Analysts note CEO Tan must balance shareholder expectations with prudent capital use, while any lack of clarity or weak earnings could weigh heavily on the stock amid volatile markets.
Go toTop